Paul Auwaerter, MD, MBA
Disclosures: Contracted Research-MicroB-Plex-Principal_Investigator-Lyme disease diagnostic research|Consulting Fee-Shinoigi-Other_Role-Scientific advisory (drug, cefiderocol)|Consulting Fee-DiaSorin-Other_Role-Scientific advisory (Lyme disease)|Consulting Fee-Collidion-Other_Role-Scientific Advisory Board (topical antiseptic)|Ownership Interest-Johnson and Johnson-Other_Role-equity holder|Consulting Fee-Adaptive BioTherapeutics-Scientific Advisory, Lyme siease - 06/26/2020
Paul G Auwaerter

Paul G Auwaerter, MD, MBA, FIDSA                                                        Short Biography



Paul G Auwaerter is the Sherrilyn and Ken Fisher Professor of Medicine at the Johns Hopkins University School of Medicine, serving as the Clinical Director for the Division of Infectious Diseases and Director of the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases.


He serves as the Executive Director of the Johns Hopkins Point of Care-Information Technology (POC-IT) Center producing the Johns Hopkins ABX (Antibiotic), JH HIV, JH Osler, JH Psychiatry and JH Diabetes Guides. Dr. Auwaerter serves as Editor-in-Chief of the ABX Guide. Over the last 20 years, it has grown to be a standard reference for ID-related clinical decision support and rational antimicrobial management. Dr. Auwaerter’s research and clinical interests include improving the diagnosis and care for patients with Lyme disease and other tick-borne infections as well as surgical infections, Epstein-Barr virus, respiratory diseases, and antibiotics resistance.  Dr. Auwaerter has led the development of therapeutic guidance for COVID-19 in the Johns Hopkins Medical Institutions as well as guiding research in the novel coronavirus. He is a Past President of the Infectious Diseases Society of America (IDSA), the largest professional society worldwide related to infectious diseases.